Cleared Traditional

K875272 - SONOLINE CF

K875272 is an FDA 510(k) clearance for SONOLINE CF, manufactured by Siemens Medical Laboratories, Inc.. The device is a Class 2 Cardiovascular device with product code DXK cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K875272 · Siemens Medical Laboratories, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1988
Decision
56d
Days
Class 2
Risk

K875272 is an FDA 510(k) clearance for the SONOLINE CF. Classified as Echocardiograph (product code DXK), Class II - Special Controls.

Submitted by Siemens Medical Laboratories, Inc. (Pleasanton, US). The FDA issued a Cleared decision on February 18, 1988 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Siemens Medical Laboratories, Inc. devices

FDA 510(k) Submission Details - K875272

510(k) Number K875272 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 24, 1987
Decision Date February 18, 1988
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXK Device Classification - Class 2, Special Controls

Product Code DXK Echocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXK Echocardiograph

All 47
Devices cleared under the same product code (DXK) and FDA review panel - the closest regulatory comparables to K875272.
RT5000 W/QUANTI. SPEC. DOPPLER, CW DOPP. MODIFICA.
K871555 · General Electric Co. · Mar 1988
GENESIS II, 2.5/5.0 MHZ S.E/5.0MHZ/3.5 16/19 MM AN
K873032 · Biosound, Inc. · Feb 1988
SERIES 77000 ULTRASOUND IMAGING SYSTEM
K873762 · Hewlett-Packard Co. · Feb 1988
GENESIS II
K871697 · Biosound, Inc. · Nov 1987
MULTIPLE
K863387 · Del Mar Avionics · Sep 1987
SSD-650 LINEAR, CONVEX SECTOR, ULTRASOUND SCANNING
K871400 · Ge Medical Systems Information Technologies · Jul 1987